Dose intensified preoperative chemotherapy with doxorubicin/docetaxel in operable breast cancer - A phase II trial

被引：0
|
作者：
Blohmer, JU
Tulusan, AH
Jackisch, C
Kaufmann, M
Costa, SD
von Minckwitz, G
Eiermann, W
机构：
[1] Univ Frankfurt, Womens Hosp, D-6000 Frankfurt, Germany
[2] Univ Munster, Womens Hosp, D-4400 Munster, Germany
[3] Univ Bayreuth, Womens Hosp, Bayreuth, Germany
[4] Univ Bern, Womens Hosp, Berlin, Germany
[5] Rot Kreuz Krh, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
33P
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [41] Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer
    Fasano, Julie
    Hershman, Dawn
    Novik, Yelena
    Levinson, Benjamin
    Blozie, Kim
    Tiersten, Amy D.
    BREAST CARE, 2010, 5 (01) : 17 - 21
  • [42] Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies
    Sparano, JA
    SEMINARS IN ONCOLOGY, 1998, 25 (06) : 10 - 15
  • [43] Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
    Peter Schmid
    J. Krocker
    R. Kreienberg
    P. Klare
    K. Kittel
    H. Sommer
    G. Heinrich
    T. Steck
    W. Lichtenegger
    D. Elling
    S. Kümmel
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 401 - 406
  • [44] Preoperative chemotherapy with epidoxorubicin and docetaxel in primary breast cancer
    Wenzel, C
    Schmidinger, M
    Locker, GJ
    Rudas, M
    Taucher, S
    Gnant, M
    Jakesz, R
    Steger, GG
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S203 - S203
  • [45] Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
    Schmid, Peter
    Krocker, J.
    Kreienberg, R.
    Klare, P.
    Kittel, K.
    Sommer, H.
    Heinrich, G.
    Steck, T.
    Lichtenegger, W.
    Elling, D.
    Kuemmel, S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 401 - 406
  • [46] Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial
    Manabu Futamura
    Yasuko Nagao
    Kazuhiro Ishihara
    Makoto Takeuchi
    Takumi Nakada
    Yoshihiro Kawaguchi
    Masayoshi Asano
    Iwao Kumazawa
    Takashi Shiroko
    Kasumi Morimitsu
    Ryutaro Mori
    Masahito Nawa
    Toshio Shimokawa
    Kazuhiro Yoshida
    Breast Cancer, 2017, 24 : 615 - 623
  • [47] A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
    Schneeweiss, A.
    Marme, F.
    Ruiz, A.
    Manikhas, A. G.
    Bottini, A.
    Wolf, M.
    Sinn, H. -P.
    Mansouri, K.
    Kennedy, L.
    Bauknecht, T.
    ANNALS OF ONCOLOGY, 2011, 22 (03) : 609 - 617
  • [48] Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer:: A randomized phase II trial
    Schneeweiss, Andreas
    Lauschner, Ilka
    Ruiz, Amparo
    Guerrero, Angel
    Sanchez-Rovira, Pedro
    Segui, Miguel Angel
    Goerke, Kay
    Wolf, Michael
    Manikhas, Alexey G.
    Wacker, Juergen
    Marme, Frederik
    Lichter, Peter
    Sinn, Hans-Peter
    Sohn, Christof
    Mansouri, Kambiz
    Bauknecht, Thomas
    Hahn, Meinhard
    CLINICAL BREAST CANCER, 2007, 7 (07) : 555 - 558
  • [49] Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    Fisher, B
    Bryant, J
    Wolmark, N
    Mamounas, E
    Brown, A
    Fisher, ER
    Wickerham, DL
    Begovic, M
    DeCillis, A
    Robidoux, A
    Margolese, RG
    Cruz, AB
    Hoehn, JL
    Lees, AW
    Dimitrov, NV
    Bear, HD
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2672 - 2685
  • [50] Operable breast cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation.
    Guarneri, V
    Frassoldati, A
    Ficarra, G
    Giovannelli, S
    Borghi, F
    Puglisi, F
    Mansutti, M
    Andreetta, C
    Banna, G
    Masci, G
    Santoro, A
    Boni, C
    Bisagni, G
    Michelotti, A
    Crispino, S
    Conte, PF
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S222 - S222
12345